Irbesartan in patients with heart failure and preserved ejection fraction.
Explore this paper's citation graph
Summary
Irbesartan did not improve the outcomes of patients with heart failure and a preserved left ventricular ejection fraction and there were no significant differences in the other prespecified outcomes.
- Type
- article
- Published
- 2008-12-04
- Cited by
- 1,895
- References
- 50
- Access
- Open access
- OpenAlex
- https://openalex.org/W2068519950
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:14301108
Keywords
Irbesartan, Medicine, Hazard ratio, Heart failure, Ejection fraction
References
- Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.
- Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey.
- Neurohumoral pathways in heart failure with preserved systolic function.
- Cardiovascular morbidity and mortality in the losartan intervention for end point reduction in hypertension study (LIFE): a randomised trial against atenolol☆
- Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
- Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo.
- What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease?
- Population-based detection of systolic and diastolic dysfunction with amino-terminal pro-B-type natriuretic peptide.
- Aldosterone in congestive heart failure.
- Perindopril for elderly people with chronic heart failure: the PEP‐CHF study
- Posting Presentations at Medical Meetings on the Internet
- Do patients with suspected heart failure and preserved left ventricular systolic function suffer from “diastolic heart failure” or from misdiagnosis? A prospective descriptive study
- A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.
- ECM remodeling in hypertensive heart disease.
- Pathways involved in the transition from hypertension to hypertrophy to heart failure. Treatment strategies
- New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function.
- The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Heart Failure Validation Study: diagnosis and prognosis.
- Radial artery conduit for coronary revascularization: as good as an internal thoracic artery?
- New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment.
- Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective.
Cited by
- Rhythm control in heart failure patients with atrial fibrillation: contemporary challenges including the role of ablation.
- Update on renin-angiotensin-aldosterone blockade in heart failure
- Pulmonary hypertension associated with left ventricular diastolic dysfunction.
- Insuficiencia cardíaca con fracción de eyección normal
- microRNA-21 promotes cardiac fibrosis and development of heart failure with preserved left ventricular ejection fraction by up-regulating Bcl-2.
- Cardiac Dysfunction and Prolonged Hemodynamic Deterioration After Implantable Cardioverter-Defibrillator Shock in Patients With Systolic Heart Failure
- The role of aldosterone receptor antagonists in the management of heart failure: An update
- Death by oxymoron? The enigma of heart failure with preserved ejection fraction.
- Too much is too much: evidence against dual RAAS inhibition in hypertensives with heart failure symptoms.
- Association between guideline recommended drugs and death in older adults with multiple chronic conditions: population based cohort study
- Deliberations on Diastolic Heart Failure.
- Abdominal Obesity Is Associated With an Increased Risk of All-Cause Mortality in Patients With HFpEF.
- Blood pressure targets for hypertension in patients with type 2 diabetes.
- Contemporary Management of Heart Failure in the Elderly
- Prognostic impact of chronic obstructive pulmonary disease on adverse prognosis in hospitalized heart failure patients with preserved ejection fraction - A report from the JASPER registry.
- A dipeptidyl peptidase-IV inhibitor improves diastolic dysfunction in Dahl salt-sensitive rats.
- Exercise intolerance in heart failure: update on exercise parameters for diagnosis, prognosis and therapeutic interventions
- The PARAGON-Heart failure trial – another disappointment for heart failure patients with hypertension and preserved ejection fraction
- [Management of heart failure: a challenge for healthcare systems].
- Guidelines for the prevention, detection and management of chronic heart failure in Australia, 2006.
Related papers
- Phenotyping Heart Failure According to the Longitudinal Ejection Fraction Change: Myocardial Strain, Predictors, and Outcomes
- Relationship Among Plasma Brain Natriuretic Peptide(BNP) Levels,Left Ventricular Ejection Fraction(LVEF) and Left Ventricular End-Diastolic Diameter(LVEDD) in Patients with Heart Failure
- Relations between heart failure, ejection fraction, arrhythmia suppression and mortality: analysis of the Cardiac Arrhythmia Suppression Trial.
- The E/e′ ratio on echocardiography as an independent predictor of the improvement of left ventricular contraction in patients with heart failure with reduced ejection fraction
- Different Implication of Elevated B‐Type Natriuretic Peptide Level in Patients with Heart Failure with Preserved Ejection Fraction and in Those with Reduced Ejection Fraction
- A Study on the Efficacy of AngiotensinII Receptor Antagonist in the Treatment of Congestive Heart Failure
- Role of Echocardiography in the Diagnosis of Heart Failure with Preserved Left Ventricular Systolic Function: Update 2013
- Correlation of Cardiac Troponin I with Left Ventricular Systolic Function in Patients with Acute ST-segment Elevated Myocardial Infarction
- Value of BNP in the Evaluation of Cardiac Function and Diagnosis of Congestive Heart Failure
- [Heart failure with preserved ejection fraction].